Males of many species, ranging from humans to insects, are more susceptible than females to parasitic, fungal, bacterial, and viral infections. One mechanism that has been proposed to account for this difference is the immunocompetence handicap model, which posits that the greater infectious disease burden in males is due to testosterone, which drives the development of secondary male sex characteristics at the expense of suppressing immunity. However, emerging data suggest that cell-intrinsic (chromosome X and Y) sex-specific factors also may contribute to the sex differences in infectious disease burden. Using a murine model of influenza A virus (IAV) infection and a panel of chromosome Y (ChrY) consomic strains on the C57BL/6J background, we present data showing that genetic variation in ChrY influences IAV pathogenesis in males. Specific ChrY variants increase susceptibility to IAV in males and augment pathogenic immune responses in the lung, including activation of proinflammatory IL-17-producing γδ T cells, without affecting viral replication. In addition, susceptibility to IAV segregates independent of copy number variation in multicopy ChrY gene families that influence susceptibility to other immunopathological phenotypes, including survival after infection with coxsackievirus B3. These results demonstrate a critical role for genetic variation in ChrY in regulating susceptibility to infectious disease. 
S
easonal infection with influenza A virus (IAV) is a significant threat to human health. IAV infects ∼15% of the world's population annually, resulting in ∼1 million deaths (1) . Throughout history, multiple pandemics (three per century over the last 300 y) confirm the importance of IAV, and in the 20th century, three pandemics in particular have been exceptionally devastating.
Epidemiologic evidence from both seasonal outbreaks and pandemics suggests that morbidity and mortality are significantly greater in women than in men (2) . For example, a 2010 report from the World Health Organization concluded that the outcomes of pandemic IAV, as well as of avian H5N1, are generally worse in females (3). However, in epidemiological studies in which age and sex were included as covariates, the data indicate that incidence and severity change as a function of age, with more males affected from birth through age 15 y and more females affected across all postpubertal age ranges (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Importantly, these data suggest that nonendocrine cell-intrinsic (genetic) sex-specific factors may contribute to disease susceptibility in males. In this regard, the concept that genes on the X and Y chromosomes (ChrX and ChrY) may influence sex differences is being increasingly recognized (18) (19) (20) (21) , and it was recently suggested that the widely expressed ancestral singlecopy ChrY genes may function as dosage-sensitive regulators of gene expression, translation, and protein stability, and as such may play essential roles in male viability, development, and sex differences in health and disease (22) .
The age-by-sex interaction seen in IAV infection is strikingly reminiscent of the age-dependent sex differences in immune responsiveness and susceptibility to experimental autoimmune encephalomyelitis (EAE) in SJL/J mice, which are controlled by genetic variation in ChrY (23) (24) (25) . Moreover, with respect to viral infections, we reported that genetic variation in ChrY influences both survival following infection with Coxsackievirus B3 virus (CVB3) (26) and susceptibility to CVB3-induced autoimmune myocarditis (27) . To address whether genetic variation in ChrY is capable of influencing susceptibility to IAV and the associated sex differences, we studied the susceptibility of a panel of ChrY consomic strains on the C57BL/6J background (B6-ChrY), and report that genetic variation in ChrY controls susceptibility to IAV in male mice, as well as the observed sex differences. In addition, we show that ChrY variation controlling increased susceptibility to IAV is associated with augmented pathogenic immune responses in the lung, including elicitation of proinflammatory IL-17-producing γδ T cells, without affecting viral replication.
Results and Discussion

Genetic Variation in ChrY Controls Susceptibility to IAV in Males and
Influences Sex Differences in Susceptibility to IAV. To assess the role of ChrY genetic variation on susceptibility to IAV infection, we studied male mice from a panel of 11 B6-ChrY consomic strains of mice using mouse-adapted Puerto Rico A/PR/8/34 H1N1 (PR8) IAV by challenging them with 5 × 10 3 egg infectious units (EIU), equivalent to ∼1 B6-LD 50 . A significant overall effect of strain on the survival of male mice was detected among the B6-ChrY consomic strains studied (χ 2 = 49.5, df = 10, P < 0.0001) (Fig. 1) . When each B6-ChrY consomic line was compared with
Significance
Including sex and gender into preclinical research is central to delineating the mechanisms contributing to sex differences in health and disease. The majority of sex differences in susceptibility to infectious diseases, such as influenza A virus (IAV), are believed to be due to the influence of sex hormones on the immune system; however, the idea that sex chromosomes also may influence infectious disease susceptibility is being increasingly recognized. Our finding that genetic variation in chromosome Y (ChrY) influences the survival of male mice following IAV infection, and the associated sex differences in IAV susceptibility, further establishes a critical role for ChrY in controlling the male-specific regulatory genome related to infectious disease susceptibility. To test whether or not the effect of ChrY on IAV susceptibility in males correlates with weight loss, we regressed the strain distribution pattern (SDP) for percent survival against the SDP for mean maximum percent weight loss. Although a significant effect of ChrY on mean maximum percent weight loss was detected (F = 2.0, P = 0.03), mean maximum % weight loss was not significantly associated with survival (F = 0.7, P = 0.4; r = −0.3, P = 0.4) (SI Appendix, Fig. S1 ). Similarly, mean % weight loss was not correlated with survival among the B6-like (F = 0.1, P = 0.8; r = 0.2, P = 0.8) or ST-like (F = 2.0, P = 0.3; r = −0.6, P = 0.3) strains. Taken together, these data establish that genetic variation in ChrY influences survival of male mice following primary infection with IAV, and does so independent of weight loss.
B6,
To assess the impact of ChrY genetic variation on the sex difference in susceptibility to IAV, we pooled the male consomic survival data into two groups, B6-like and ST-like (based on significance of difference in survival compared with B6; see above), and compared these data with survival data for B6 male and female mice (Fig. 2) . Compared with B6 females, both B6 (χ 2 = 8.2, df = 1, P = 0.004) and B6-like males (χ 2 = 11.2, df = 1, P = 0.0008) were significantly less susceptible to IAV infection, as expected; however, ST-like males were not significantly different from B6 females (χ 2 = 1.1, df = 1, P = 0.5). The sex difference seen between B6 and B6-like males vs. B6 females, whereby females display greater susceptibility to IAV, is consistent with the previously reported sex difference between B6 males and females (2, 28) , and our results suggest that this sex difference can be overridden by ChrY variants in the ST-like group. Taken together, these data establish that genetic variation in ChrY influences the survival of male mice following primary infection with IAV, and thus contributes to the associated sex differences.
Previous work using the four core genotypes model on the B6 background [B6-XX, B6-XY, B6.Cg-Srydl1Rlb, and B6.CgTg(Sry)2EiSry dl1Rlb ] has shown that the sex chromosome complement does not impact the susceptibility to IAV (29) . However, the effect of natural genetic variation in ChrY on susceptibility to IAV was not addressed in this model, and our current findings show that pairing of different ChrY with B6-autosomes and B6-ChrX can in fact influence IAV susceptibility.
ChrY Influences Pathogenic Inflammatory Responses in IAV-Infected
Lung. To understand the mechanisms underlying the increased susceptibility to IAV in ST-like ChrY consomic male mice, we compared B6 mice and ChrY PWD mice. The latter were selected because they exhibited the second-highest mortality overall, and because the PWD/PhJ strain is highly genetically divergent compared with B6 (30, 31) . Male B6 and ChrY PWD mice were infected with the same dose of IAV as in the mortality studies, followed by isolation of whole-lung RNA at the peak of viral replication, on day 6 postinfection, just before the onset of IAVinduced mortality (Fig. 1) . Viral replication was assessed using quantitative RT-PCR (qRT-PCR) for viral RNA, and no differences between B6 and ChrY PWD mice were found (SI Appendix, Fig. S2A ), suggesting that the increased mortality in ChrY PWD mice is not due to enhanced viral replication. In addition, analysis of bronchoalveolar lavage (BAL) fluid did not reveal a significant difference in the number and type of leukocytes between the two strains (SI Appendix, Fig. S2 B and C), or in the production of the proinflammatory cytokines IL-6, IFNγ, and TNFα (SI Appendix,
To obtain a global unbiased perspective of the pathogenic events at the site of infection, we performed transcriptomic profiling of the infected lung. We found that 32 genes showed significantly higher expression in ChrY PWD lungs relative to B6 lungs, whereas 98 genes showed lower expression ( Fig. 3 A and B) . Strikingly, whereas the majority (20 of 32) of the genes showing increased expression in ChrY PWD lungs represented coding genes, only a minority of the of the genes with decreased expression were coding (14 of 98) (Fig. 3B) . Instead, the majority (63 of 98) of genes showing decreased expression in ChrY PWD lungs were classified as small RNAs, suggesting that the presence of a heterologous ChrY may regulate the expression of small RNAs as part of its mechanism regulating global gene expression. In this regard, we previously showed that ChrY can regulate global gene expression, including the expression of splice variants and miRNA, in a cell type-specific and background-specific fashion (27) .
Importantly, several genes exhibiting higher expression in ChrY PWD lungs were of immunologic relevance: two genes coding for the γδ T-cell receptor (TCR) and several genes encoding Ig heavy and light chains, suggesting potential differences in recruitment and/or activation of γδ T cells and B cells (Fig. 3C ). The former is of particular interest, given the reported association between IL-17-producing lung γδ T cells and acute Overall significance of differences in survival was determined using the logrank (Mantel-Cox) test, with post hoc comparisons of each strain vs. B6 computed using the Dunnett-Hsu correction for multiple comparisons. A significant effect of ChrY on overall survival was detected (χ 2 = 49.5, df = 10, P < 0.0001). The significance of the difference from B6 is indicated next to each strain name, designated as follows: *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. The following strains were not significantly different from B6, as indicated by a lack of a symbol next to the strain name: ChrY Fig. 1 . The survival data for female B6 mice were compared with that of B6 males, the pooled survival data for B6-like males, and ST-like males. The significance of differences in survival compared with B6 females was determined using the log-rank (Mantel-Cox) test and is indicated as follows: **P ≤ 0.01; ***P ≤ 0.001; ns, not significant.
lung injury caused by IAV infection (32) . To confirm the transcriptional profiling results, we isolated cells from infected lungs of B6 and ChrY PWD mice at day 6 after PR8 infection. Flow cytometry analysis identified a twofold increase in the number and proportion of γδ T cells in ChrY PWD lungs compared with B6, which was not observed for αβ T cells (Fig. 4 A and B) . Despite the increase in Ig gene expression in ChrY PWD lungs compared with B6 (Fig. 3C) , we did not observe a significant difference in the number or proportion of B cells in the lung (Fig. 4 A and B) .
Lung γδ T cells are divided into several major subsets based on their TCR use: Vγ1 + , Vγ4 + , and Vγ6 + (33). The Vγ4 + and Vγ6 + subsets are of particular interest, given their propensity to produce IL-17 and promote inflammation in the lung and other organs (34, 35) . Analysis of the Vγ1 + and Vγ4 + subsets in the infected lung revealed that the increase in γδ T cells in ChrY PWD lungs can be accounted for largely by an increase in Vγ4 + and Vγ1
− γδ T cells (most likely Vγ6 + ) (Fig. 4 C and D) . We next examined cytokine production by lung γδ T cells using intracellular staining and flow cytometry, and found a strong increase in IL-17-producing γδ T cells in ChrY PWD lungs compared with B6, whereas no significant difference in IFNγ-producing cells was observed (Fig. 4 E and F) . Interestingly, no significant differences in IL-17 or IFNγ production by αβ T cells were observed (Fig. 4 G and H Susceptibility to IAV Infection. The current paradigm is that the sex differences in IAV infection is believed to be primarily a function of the cell-extrinsic immunostimulatory effects of 17β-estradiol and immunosuppressive effects of testosterone (T) on the immune system (36) . To test whether the effect of ChrY on IAV susceptibility in males is related to ChrY-dependent differences in adult serum T, we regressed the SDP for T levels in naïve adult mice measured in our previous studies (26, 27) against the SDP for survival following primary infection. Although a significant effect of ChrY on adult serum T levels was detected (F = 3.2, P = 0.001) (26, 27) , T levels were not significantly associated with survival (F = 2.8, P = 0.1; r = 0.5, P = 0.1) (SI Appendix, Fig. S3 ), suggesting that ChrY-dependent differences in adult serum T levels are unlikely to be major drivers of differential susceptibility to IAV in ChrY consomic mice, although a differential effect of ChrY on T levels and/or ChrY-T interactions (19) during IAV infection cannot be completely ruled out. The data are marginally suggestive (at P = 0.1) of a possible positive relationship between T levels and survival post-IAV challenge, which is in agreement with work by the Klein group (29, 37) demonstrating that T is protective in IAV infection.
Exposure to different levels of androgens during development plays an important role in programming many adult phenotypes and provides a proxy for determining differential exposure to androgen levels during development (38) (39) (40) (41) . Therefore, to examine whether the effect of ChrY on IAV susceptibility is related to developmental differences in ChrY-dependent T levels, we compared the SDPs for IAV survival with the 5-wk-old weight-adjusted anogenital distance index (AGDI) (42), as described previously (21) . Although a significant effect of ChrY on AGDI was detected (F = 3.8, P < 0.0001), this was not significantly associated with IAV susceptibility (F = 1.6, P = 0.2; r = 0.4, P = 0.2) (SI Appendix, Fig. S4 ), suggesting that differential susceptibility to IAV is unlikely to be a function of ChrYdependent differences in T exposure during development. 
Differential Susceptibility to IAV Does Not Correlate with Sry Alleles Defining Mus mus musculus and Mus mus domesticus A and B Type
ChrYs. Sry (sex-determining region of ChrY) expression alleles, which when inherited by B6 mice heterozygous for the t-complex encoded TOrleans mutation on Chr17, lead to varying degrees of sex reversal (43) (44) (45) . We have previously shown that neither survival of male CVB3-infected B6-ChrY mice nor the susceptibility to EAE correlate with the distribution of these Sry expression alleles (26, 27) . Furthermore, we found that Sry expression alleles do not influence the level of adult T production in the B6-ChrY consomic strains (26) . To examine whether Sry alleles influence susceptibility to IAV, we compared the SDP of Sry alleles with the SDP for survival following primary infection with IAV. The results revealed that Sry alleles, which define M. m. musculus and M. m. domesticus A and B type ChrYs (43-45), do not correlate with susceptibility to IAV (r = −0.3, P = 0.3) (SI Appendix, Fig. S5 ).
Copy Number Variation in ChrY Multicopy Genes Does Not Correlate
with Survival of Male Mice Following Primary Infection with IAV. The long arm of murine ChrY encodes several multicopy gene families, which exhibit significant strain-specific copy number variation (CNV), and the physiological roles of which are only beginning to be understood (20, 21) . Importantly, our studies in EAE and CVB3-induced autoimmune myocarditis revealed a strong association between CNV in multicopy ChrY genes and susceptibility to these autoimmune diseases (27, 46) . Based on these results, we hypothesized that CNV in multicopy ChrY genes may also control survival following primary infection with IAV. Unexpectedly, CNV in any of the ChrY multicopy genes did not correlate with differences in survival following primary infection with IAV (Table 1) .
To test whether the lack of an association between CNV and IAV pathogenesis is a general feature of viral infections, we examined the relationship of CNV in ChrY multicopy genes (46) , and Ssty2 revealed that CVB3 survival is in fact associated with CNV at Ssty1 (F = 15.5, P = 0.002; r = −0.8, P = 0.005), Ssty2 (F = 7.4, P = 0.02; r = −0.6, P = 0.02), and Rbmy (F = 6.9, P = 0.02; r = 0.6, P = 0.02) ( Table 1) .
The lack of an association between CNV in ChrY multicopy genes and susceptibility to IAV suggests that the genetic variation underlying the phenotypic differences in survival following primary infection with IAV is distinct from that controlling susceptibility to EAE (Sly, Ssty1, Ssty2, Sry, and Rbmy), CVB3-induced AI myocarditis (Sly and Rbmy), and survival following CVB3 infection (Ssty1, Ssty2, and Rbmy). In this regard, a comparison of the SDPs for survival following primary infection with IAV and that for CVB3 (F = 2.3, P = 0.2; r = −0.5, P = 0.2) (SI Appendix, Fig. S6 ) further supports the concept that the ChrY genetic variation underlying the phenotypic differences in survival following primary infection with IAV and CVB3 is distinct.
Taken together, these data suggest that unidentified ChrY genetic variation that is unrelated and not linked to CNV in ChrY multicopy genes controls survival following IAV infection, and modifies the sex differences in IAV pathogenesis. In this regard, it has been suggested that the widely expressed singlecopy ChrY genes function as regulators of gene expression, translation, and protein stability, and as such likely play essential roles in male viability, development, and sex differences in health and disease (22) . However, directly testing the hypothesis that polymorphism in one or more of these genes controls the susceptibility to IAV and the sex differences will require sequencing the ∼3.5-Mb short arm of ChrY, the gene rich region encoding these genes (47) , across each of the strains used in this study, as was recently done for the male-specific region of ChrY in the rat where MSY genetic variation was reported to alter a broad range of inbred rat phenotypes (48) .
Notwithstanding, it is worth noting that a spontaneous deletion in the long arm of ChrY has been shown to influence lymphocyte development (49) , raising the possibility that the genome-wide regulatory activity of ChrY also may involve changes in the spatial positioning of X-linked and autosomal genes associated with transcription, that is, movement toward or away from transcriptional centers (50) . Our findings demonstrate that ChrY variants regulate the expression of small RNAs with striking directionality (Fig. 3C) , further strengthening the concept of epigenetic or structural regulation of genome-wide gene expression by ChrY. In addition, and consistent with structural regulation, none of the differentially expressed genes in our analysis were found to reside on ChrY.
The primary mechanisms through which IAV infection leads to death focus on the relative contribution of direct viral cytopathicity vs. immunopathologically mediated damage, leading to loss of homeostasis and respiratory function. The direct cytopathicity model posits that although the innate immune system reaches a high level of activation (51) (52) (53) (54) , it nevertheless is incapable of containing the pathogen before viral cytopathicity causes loss of lung homeostasis (55, 56) . In this view, the inflammatory response is a correlate of the damaging infection and not directly immunopathologic. In contrast, the immunopathology model posits that lethality is immunopathologic in nature, with lung function dysregulated largely through the damaging effects of leukocytes on epithelial and endothelial cells (57, 58) . Our finding that differential susceptibility to IAV infection between B6 and B6-ChrY PWD mice is associated with a strongly augmented presence of proinflammatory IL-17-producing γδ T cells belonging to the Vγ4 + and Vγ1
−
Vγ4
− subsets, and not with differences in viral replication, is consistent with the role of ChrY genetic variation in mediating its effects via immunopathologic damage rather than viral cytopathicity. Additional studies are needed to address whether this mechanism is common to all ST-like ChrY consomic male mice. Interestingly, our finding that differential survival was not associated with differences in the number of neutrophils in BAL fluid suggests that ChrY genetic variation controlling IAV-induced lethality does so independently of the recently described chemokine-driven feedforward circuit involving proinflammatory neutrophils (59) .
With respect to the role of human ChrY genetic variation in viral infections, an association between ChrY haplogroup I and AIDS progression in HIV-infected men has been identified. Among European Americans, men inheriting ChrY haplogroup I show accelerated progression to AIDS and related death, as well as delayed HIV-1 viral suppression during HAART therapy, compared with other ChrY haplogroups (60) . Interestingly, a genetic evaluation of ChrY haplogroup I has not identified the The significance of associations was determined by linear regression (F) and the Pearson product-moment correlation test, except for Rbmy31, which was determined using the Spearman rank-order correlation test. Numbers in parentheses are the associated P values. particular genetic variant associated with AIDS progression (61) . Taken together, these observations and our present results suggest that genetic variation in ChrY plays a critical role in regulating infectious disease pathogenesis in mammals. Clearly, only when we have obtained a detailed understanding of the sex-specific regulatory genomes in infectious disease pathogenesis will we be able to fully appreciate the mechanisms underlying sex differences in health and disease, and move forward with modeling sex-specific therapeutic interventions based on targeting cell-extrinsic and/or cell-intrinsic sex-specific pathways.
Materials and Methods
Mice. All of the mice used in this study were bred and maintained in the animal facility at the University of Vermont. The B6-ChrY consomic panel of mice used in this study was purchased from The Jackson Laboratory. The number of backcrosses performed before cryopreservation is indicated next to each strain when this information was available on The Jackson Laboratory website. Males from each consomic strain were backcrossed to female C57BL/ 6J mice for an additional five generations before experimentation: C57BL/6J (B6), C57BL/6J-ChrY Viruses and Infection. The H3 variant of CVB3 was made from an infectious cDNA clone as described previously (62) . Mice were infected with 50 pfu of virus i.p. in 0.5 mL of PBS (26) . Mouse-adapted Puerto Rico A/PR/8/34 H1N1 (PR8) virus was used to infect mice. Male and female mice were anesthetized using isoflurane and infected intranasally with 5 × 10 3 EIU (∼1 LD 50 ) of PR8 in 0.05 mL of PBS under brief isoflurane anesthesia. Mice were monitored daily for weight loss and other clinical signs of illness. Animals that became grossly moribund were euthanized. Cytospins were examined on a light microscope using 10× and 40× objectives, and differential cell counting was performed by a blinded observer who identified cell types by morphology in 10 different randomly selected fields per slide. BAL fluid cytokine (IL-6, IFNγ, TNFα, IL-4, GM-CSF, and IL-17) production was examined by ELISA using capture and detection antibody pairs, as described previously (63) . The latter three cytokines were below the limit of detection.
After BAL fluid collection, lungs were used for RNA extraction, as follows. Lungs were removed and placed into tubes containing 2.3-mm zirconia/silica beads (BioSpec) and lysis Buffer RLT (RNEasy Miniprep Kit; Qiagen). Lungs were homogenized using a BeadBeater homogenizer (BioSpec), and RNA was extracted in accordance with the manufacturer's protocol. Influenza viral load was determined by measuring the RNA expression of the viral PA gene by qRT-PCR, which has been shown to correspond to viral titers by plaque assays (64) . The following primers were used: PR8-PA forward, GAGCC-TATGTGGATGGATTC; PR8-PA reverse, TGCAGTTCTGCCAGTACTTG. Data were normalized to the expression of the housekeeping gene, B2m. SYBR Green-based qRT-PCR was performed as described previously (65) .
In a second series of experiments, animals were infected and euthanized as above. To isolate lung leukocytes, lungs were inflated with 1 mL of enzymatic digestion buffer (DMEM; HyClone), 1 mg/mL collagenase type IV (Life Technologies), and 0.2 mg/mL DNase (Sigma-Aldrich), after which they were dissected away from the trachea and finely minced with scissors. Lung tissue was resuspended in enzymatic digestion buffer and shaken at 200 rpm at 37°C for 20 min. The samples were triturated twice with a 16-gauge needle, with another intermediate shaking step of 20 min. Red blood cells were lysed using Gey's solution and the digested tissue was washed with 5 mL PBS and 5% (vol/vol) FCS before being passed through a 100-μm-pore filter. Cells were counted as above, and 2 million cells were used for multicolor surface staining and flow cytometry, using fluorophore-conjugated antibodies to detect the following antigens: CD45, CD19, CD11b, TCRβ, pan-TCRγδ, Vγ1, and Vγ4 (Biolegend). Dead cells were excluded using the Live-Dead UV-Blue staining kit (Life Technologies).
For intracellular cytokine staining, another 2 million cells were stimulated with 5 ng/mL PMA and 250 ng/mL ionomycin (Sigma-Aldrich) in the presence of Golgi Plug reagent (BD Biosciences) for 4 h. Cells were then labeled with the UV-Blue Live-Dead fixable stain and then labeled for the following surface antigens: CD11b, CD4, CD8, pan-TCRγδ, and TCRβ. Cells were then fixed with 1% paraformaldehyde (Sigma-Aldrich), permeabilized with PBS containing 0.2% saponin, and labeled with anti-IL-17A and anti-IFNγ antibodies (Biolegend). Labeled cells were analyzed on an LSRII flow cytometer (BD Biosciences).
Transcriptional Profiling of PR8-Infected Lungs. Whole-lung RNA was isolated as described above. RNA integrity and quality were assayed using an Agilent 2100 Bioanalyzer. Based on RNA quality, five RNA samples per group (B6 and B6.ChrY PWD ) were selected for microarray analysis. Each sample represented an individual mouse. Microarray analysis was performed using the Clariom D platform with a WT PLUS Target Prep Kit (Affymetrix) at the University of Vermont's Vermont Genetics Network Microarray Facility, as follows. RNA (100 ng) was used to synthesize cDNA through a First-Strand reverse-transcription reaction and Second-Strand RNA degradation reaction, using reagents from the GeneChip WT PLUS Reagent Kit (Affymetrix). cRNA was then synthesized through an overnight (16-h) in vitro transcription reaction, which uses a T7 RNA polymerase. The cRNA was purified using an Affymetrix magnetic bead protocol. Sample concentrations were determined using a 40 μg/mL/A260 constant on a Nanodrop 1000 spectrophotometer.
Approximately 15 μg of cRNA was then used to synthesize sense, singlestrand cDNA using reagents from the GeneChip WT PLUS Reagent Kit. Any remaining cRNA template was hydrolyzed with RNase H. Single-stranded cDNA was purified using an Affymetrix magnetic bead protocol. Sample concentrations were determined using a 33 μg/mL/A260 constant on a Nanodrop 1000 spectrophotometer. Approximately 5.5 μg of singlestranded cDNA was fragmented using uracil DNA-glycosylase (10 U/μL) and apurinic/apyrimidinic endonuclease 1 (1,000 U/μL), provided in the GeneChip WT PLUS Reagent Kit. Samples were then labeled with biotin using terminal deoxynucleotidyl transferase (30 U/μL), also provided in the GeneChip WT PLUS Reagent Kit. The efficiency of the fragmentation and labeling reactions was verified using NeutrAvidin (10 mg/mL) with a gel-shift assay. Samples were combined with a hybridization mix, injected into mouse Clariom D arrays, and placed in an Affymetrix GeneChip Hybridization Oven 645 at 45°C and 60 rpm for 16.5 h overnight. Arrays were stained using an Affymetrix GeneChip Fluidics Station 450 and scanned with an Affymetrix GeneChip Scanner 3000 7G.
Raw intensity CEL files were imported into Expression Console software (Affymetrix), and CHP files were generated for gene-level analysis. CHP files were imported into Transcriptome Analysis Console software (Affymetrix), and gene level differential expression analysis was performed using the default one-way between-subject unpaired ANOVA settings (jfold changej>2; P < 0.05, ANOVA) to identify genes exhibiting significantly different expression between B6 and B6.ChrY PWD lungs. Array results have been deposited into the Gene Expression Omnibus system.
Statistical Analysis. Statistical analyses were performed using GraphPad Prism version 6.07 and SAS version 9.4 (SAS Institute). The specific tests used to assess the significance of the observed differences are detailed in the figure legends. A P value of ≤0.05 was considered to indicate statistical significance.
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